e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement
Masoud Dara, Pierpaolo de Colombani, Roumyana Petrova-Benedict, Rosella Centis, Jean-Pierre Zellweger, Andreas Sandgren, Einar Heldal, Giovanni Sotgiu, Niesje Jansen, Rankica Bahtijarevic, Giovanni Battista Migliori, on behalf of the members of the Wolfheze Transborder Migration Task Force
Source:
Eur Respir J 2012; 40: 1081-1090
Journal Issue:
November
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Masoud Dara, Pierpaolo de Colombani, Roumyana Petrova-Benedict, Rosella Centis, Jean-Pierre Zellweger, Andreas Sandgren, Einar Heldal, Giovanni Sotgiu, Niesje Jansen, Rankica Bahtijarevic, Giovanni Battista Migliori, on behalf of the members of the Wolfheze Transborder Migration Task Force. Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement. Eur Respir J 2012; 40: 1081-1090
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Evaluation of a large-scale tuberculosis contact investigation in the Netherlands
Source: Eur Respir J 2008; 32: 419-425
Year: 2008
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019
Fighting tuberculosis in the EU/EEA: towards the new European Union standards on tuberculosis care
Source: Eur Respir J 2016; 48: 1278-1281
Year: 2016
Active case finding of tuberculosis, Tomsk (Russia)
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results
Source: Eur Respir J 2011; 38: 1374-1381
Year: 2011
Four cases, one family: A cluster of resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
European framework to decrease the burden of TB/HIV
Source: Eur Respir J 2004; 24: 493-501
Year: 2004
The global response to rifampicin-resistant tuberculosis: Current situation and recent trends
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
The European union standards for tuberculosis care: Do they need an update?
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Childhood tuberculosis: progress requires an advocacy strategy now
Source: Eur Respir J 2012; 40: 294-297
Year: 2012
Prevalence of latent tuberculosis infection among household contacts and community controls in South India
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Tuberculosis control program in public health system (family health units) in São Luis-MA-Brazil: patients profiles and compliance
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006
Comparison of tuberculosis surveillance systems in low-incidence industrialised countries
Source: Eur Respir J 2008; 32: 1616-1624
Year: 2008
Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Knowledge and attitude about tuberculosis disease in a health workers population
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Source: Eur Respir J 2014; 44: 23-63
Year: 2014
A study of tuberculosis in an expatriate Nepalese community in South-East London
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept